RAGE was first identified as a cell surface receptor for Advanced Glycation End-products (AGEs) [5,6], the products of nonenzymatic glycation and oxidation of proteins/lipids that accumulate during physiological aging, but also in diabetes, inflammatory, and neurodegenerative diseases. Here, AGER is linked to neurodegenerative disease.